OBJECTIVES: Preoperative atrial fibrillation (PAF) has been associated with poorer early and mid-term outcomes after isolated valvular or coronary artery bypass graft surgery. Few studies, however, have evaluated the impact of PAF on early and mid-term outcomes after concomitant aortic valve replacement and coronary aortic bypass graft (AVR-CABG) surgery. METHODS: Data obtained prospectively between June 2001 and December 2009 by the Australian and New Zealand Society of Cardiac and Thoracic Surgeons National Cardiac Surgery Database Program was retrospectively analysed. Patients who underwent concomitant atrial arrhythmia surgery/ablation were excluded. Demographic and operative data were compared between patients undergoing concomitant AVR-CABG who presented with PAF and those who did not using chi-square and t-tests. The independent impact of PAF on 12 short-term complications and mid-term mortality was determined using binary logistic and Cox regression, respectively. RESULTS: Concomitant AVR-CABG surgery was performed in 2563 patients; 322 (12.6%) presented with PAF. PAF patients were generally older (mean age 76 vs 74 years; P < 0.001) and presented more often with comorbidities including congestive heart failure, chronic pulmonary disease and cerebrovascular disease (all P < 0.05). PAF was associated with 30-day mortality on univariate analysis (P = 0.019) but not multivariate analysis (P = 0.53). The incidence of early complications was not significantly higher in the PAF group. PAF was independently associated with reduced mid-term survival (HR, 1.58; 95% CI, 1.14-2.19; P = 0.006). CONCLUSIONS: PAF is associated with reduced mid-term survival after concomitant AVR-CABG surgery. Patients with PAF undergoing AVR-CABG should be considered for a concomitant surgical ablation procedure.
OBJECTIVES: Preoperative atrial fibrillation (PAF) has been associated with poorer early and mid-term outcomes after isolated valvular or coronary artery bypass graft surgery. Few studies, however, have evaluated the impact of PAF on early and mid-term outcomes after concomitant aortic valve replacement and coronary aortic bypass graft (AVR-CABG) surgery. METHODS: Data obtained prospectively between June 2001 and December 2009 by the Australian and New Zealand Society of Cardiac and Thoracic Surgeons National Cardiac Surgery Database Program was retrospectively analysed. Patients who underwent concomitant atrial arrhythmia surgery/ablation were excluded. Demographic and operative data were compared between patients undergoing concomitant AVR-CABG who presented with PAF and those who did not using chi-square and t-tests. The independent impact of PAF on 12 short-term complications and mid-term mortality was determined using binary logistic and Cox regression, respectively. RESULTS: Concomitant AVR-CABG surgery was performed in 2563 patients; 322 (12.6%) presented with PAF. PAFpatients were generally older (mean age 76 vs 74 years; P < 0.001) and presented more often with comorbidities including congestive heart failure, chronic pulmonary disease and cerebrovascular disease (all P < 0.05). PAF was associated with 30-day mortality on univariate analysis (P = 0.019) but not multivariate analysis (P = 0.53). The incidence of early complications was not significantly higher in the PAF group. PAF was independently associated with reduced mid-term survival (HR, 1.58; 95% CI, 1.14-2.19; P = 0.006). CONCLUSIONS:PAF is associated with reduced mid-term survival after concomitant AVR-CABG surgery. Patients with PAF undergoing AVR-CABG should be considered for a concomitant surgical ablation procedure.
Authors: Chris A Rogers; Gianni D Angelini; Lucy A Culliford; Radek Capoun; Raimondo Ascione Journal: Ann Thorac Surg Date: 2006-05 Impact factor: 4.330
Authors: Bruno Chiappini; Sofia Martìn-Suàrez; Antonino LoForte; Giorgio Arpesella; Roberto Di Bartolomeo; Giuseppe Marinelli Journal: Ann Thorac Surg Date: 2004-01 Impact factor: 4.330
Authors: E R Jessurun; N M van Hemel; J C Kelder; S Elbers; A B de la Rivière; J J Defauw; J M Ernst Journal: Eur J Cardiothorac Surg Date: 2000-05 Impact factor: 4.191
Authors: Mohammed A Quader; Patrick M McCarthy; A Marc Gillinov; Joan M Alster; Delos M Cosgrove; Bruce W Lytle; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2004-05 Impact factor: 4.330
Authors: Angelo B Biviano; Tamim Nazif; Jose Dizon; Hasan Garan; Jessica Fleitman; Dua Hassan; Samir Kapadia; Vasilis Babaliaros; Ke Xu; Rupa Parvataneni; Josep Rodes-Cabau; Wilson Y Szeto; William F Fearon; Danny Dvir; Todd Dewey; Mathew Williams; Michael J Mack; John G Webb; D Craig Miller; Craig R Smith; Martin B Leon; Susheel Kodali Journal: Circ Cardiovasc Interv Date: 2016-01 Impact factor: 6.546
Authors: Jesper Park-Hansen; Susanne J V Holme; Akhmadjon Irmukhamedov; Christian L Carranza; Anders M Greve; Gina Al-Farra; Robert G C Riis; Brian Nilsson; Johan S R Clausen; Anne S Nørskov; Christina R Kruuse; Egill Rostrup; Helena Dominguez Journal: J Cardiothorac Surg Date: 2018-05-23 Impact factor: 1.637
Authors: Maunu Nissinen; Joonas Lehto; Fausto Biancari; Tuomo Nieminen; Markus Malmberg; Fredrik Yannopoulos; Samuli Salmi; Juhani K E Airaksinen; Tuomas Kiviniemi; Juha E K Hartikainen Journal: Clin Cardiol Date: 2020-02-05 Impact factor: 2.882
Authors: Bartłomiej Perek; Marcin Misterski; Wojciech Stachowiak; Piotr Buczkowski; Sebastian Stefaniak; Mateusz Puślecki; Tomasz Urbanowicz; Wiktor Budniak; Marek Jemielity Journal: Kardiochir Torakochirurgia Pol Date: 2014-11-30